Oncolytics Biotech (ONCY) Tax Provisions (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Tax Provisions came in at $183112.0 in Q3 2025, up 2181.61% year-on-year from $8025.6 in Q3 2024, and up 398.49% on a QoQ basis from -$61345.6 in Q2 2025.
Oncolytics Biotech (ONCY) Tax Provisions (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 15 years of Tax Provisions data on file, last reported at $183112.0 in Q3 2025.
- On a quarterly basis, Tax Provisions rose 2181.61% year-over-year to $183112.0 in Q3 2025; TTM through Sep 2025 was $96505.3, a 183.87% increase from a year earlier, with the FY2025 full-year figure at $79000.0, down 16.84% from the prior year.
- Tax Provisions for Q3 2025 stood at $183112.0, up from -$61345.6 in the prior quarter.
- Over the last five years, Tax Provisions for ONCY reached as high as $183112.0 in Q3 2025 and fell as low as -$69458.4 in Q2 2024.
- Historically, Tax Provisions has averaged -$5309.0 across 5 years, with a median of -$16464.5 in 2024.
- Across the five-year window, Tax Provisions tumbled 240.5% in 2023 and surged 2181.61% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $44546.6 in 2021, then plunged by 194.27% to -$41992.1 in 2022, then gained by 24.78% to -$31585.0 in 2023, then surged by 47.87% to -$16464.5 in 2024, then surged by 1212.16% to $183112.0 in 2025.
- Per Business Quant data, the three most recent Tax Provisions figures were $183112.0 in Q3 2025, -$61345.6 in Q2 2025, and -$16464.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 183,112.02 |
| Jun 30, 2025 | -61,345.56 |
| Dec 31, 2024 | -16,464.53 |
| Sep 30, 2024 | -8,796.64 |
| Jun 30, 2024 | -69,458.35 |
| Dec 31, 2023 | -31,585.03 |
| Sep 30, 2023 | -5,221.51 |
| Jun 30, 2023 | -34,989.27 |
| Dec 31, 2022 | -41,992.07 |
| Sep 30, 2022 | -1,533.49 |
| Jun 30, 2022 | -19,608.52 |
| Dec 31, 2021 | 44,546.61 |
| Sep 30, 2021 | -5,680.82 |
| Sep 30, 2018 | -79.00 |
| Jun 30, 2018 | -547,758.00 |
| Mar 31, 2018 | -120.00 |
| Sep 30, 2017 | 168.00 |
| Jun 30, 2017 | 89.00 |
| Mar 31, 2017 | 63.00 |
| Sep 30, 2016 | 19.00 |